High Flow Oxygen Therapy Devices Market Global Report 2026

The high flow oxygen therapy devices market size has grown steadily in recent years. It will grow from $1.5 billion in 2025 to $1.55 billion in 2026 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to rise in chronic respiratory diseases prevalence, expansion of hospital intensive care infrastructure, adoption of conventional oxygen therapy systems, improvements in respiratory care technologies, increased demand for emergency respiratory support.

The high flow oxygen therapy devices market size is expected to see steady growth in the next few years. It will grow to $1.8 billion in 2030 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to AI-enabled predictive respiratory monitoring, growth of home healthcare and remote patient monitoring, advancements in portable oxygen therapy systems, expansion of critical care infrastructure in emerging economies, integration of smart sensors in respiratory devices. Major trends in the forecast period include AI-driven respiratory support optimization, integration of smart monitoring in high flow oxygen devices, growth of portable high flow oxygen therapy systems, increasing adoption of humidified oxygen delivery systems, expansion of home-based respiratory care solutions.

The rising prevalence of chronic respiratory diseases is expected to drive the growth of the high-flow oxygen therapy devices market going forward. Chronic respiratory diseases are long-term lung disorders, such as chronic obstructive pulmonary disease (COPD) and asthma, that affect normal breathing and require ongoing respiratory care. The growing prevalence of chronic respiratory diseases is being driven by aging populations, extended exposure to air pollution, and continued tobacco smoke consumption, all of which contribute to deteriorating lung health. High-flow oxygen therapy devices assist in managing chronic respiratory diseases by supplying heated and humidified oxygen at high flow rates, enhancing oxygenation, reducing breathing effort, and decreasing the need for invasive ventilation or frequent hospitalizations. For instance, in May 2023, according to the World Health Organization, a Switzerland-based United Nations specialized agency, chronic obstructive pulmonary disease accounted for approximately 3.5 million deaths globally, indicating a significant rise in disease burden. Therefore, the rising prevalence of chronic respiratory diseases is driving the growth of the high-flow oxygen therapy devices market.

The growing healthcare expenditure is expected to drive the growth of the high-flow oxygen therapy devices market going forward. Healthcare expenditure refers to the overall spending on health services, medical infrastructure, healthcare personnel, and advanced treatment technologies by governments, private organizations, and individuals. The rise in healthcare expenditure is driven by aging populations, the increasing prevalence of chronic diseases, and the growing demand for enhanced healthcare services and modern treatment solutions. High-flow oxygen therapy devices contribute to this trend by allowing hospitals and healthcare facilities to implement advanced respiratory support systems that improve patient outcomes, minimize complications, and reduce the duration of hospital stays. For instance, in April 2025, according to the Office for National Statistics, a UK-based government agency, government-funded healthcare accounted for the majority of healthcare expenditure in the UK and reached $322.5 billion (£258 billion) in 2024, representing a real-term increase of 2.5% compared to 2023. Therefore, the growing healthcare expenditure is driving the growth of the high-flow oxygen therapy devices market.

Leading companies operating in the high flow oxygen therapy devices market are focusing on developing innovative solutions, such as high flow nasal cannulas, to generate a small level of positive airway pressure that helps keep airways open and improves alveolar ventilation. A high flow nasal cannula is a respiratory support interface that delivers warmed, humidified air and oxygen at high flow rates through nasal prongs to assist breathing and improve gas exchange. For example, in September 2023, Intersurgical Ltd. launched the Intersurgical i-flo high flow nasal cannula. It is a single-use adult patient interface designed for delivering high flow oxygen therapy in hospital settings. It features an unobtrusive design that prioritizes both effective performance and patient comfort. Its specialized construction supports optimal delivery of high flow oxygen therapy, making it suitable for respiratory support in patients with hypoxemic respiratory failure.

Major companies operating in the high flow oxygen therapy devices market are Medtronic plc, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., ResMed Inc., Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Allied Healthcare Products Inc., Nihon Kohden Corporation, Fisher & Paykel Healthcare Corporation Limited, Jiangsu Yuyue Medical Equipment & Supply Co. Ltd., Inspired Medical Limited, Vyaire Medical Inc., Hamilton Medical AG, Intersurgical Limited, Armstrong Medical Limited, BMC Medical Co. Ltd., Micomme Medical Technology Co. Ltd., Flexicare (Group) Limited, Peak Medical Limited, Great Group Medical Co. Ltd.

North America was the largest region in the high flow oxygen therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high flow oxygen therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the high flow oxygen therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The high flow oxygen therapy devices market consists of sales of air-oxygen blenders, flow generators, respiratory gas mixers, and heated breathing circuits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.